Semaglutide or tirzepatide: how do the two compare?

Semaglutide acts on one receptor, GLP-1, while tirzepatide acts on two, GIP and GLP-1 (Wegovy prescribing information; Zepbound prescribing information). In a 72-week trial that compared them directly in adults with obesity but without type 2 diabetes, people on tirzepatide lost more weight on average (New England Journal of Medicine, 2025). Which one fits you, if either, is for you and a licensed provider to decide.

This guide explains published facts and prices. It is not medical advice: a licensed provider who knows your health history decides what is right for you.

One target or two?

Both medications act on the GLP-1 receptor. The Wegovy label says semaglutide selectively binds to and activates that receptor (Wegovy prescribing information). Tirzepatide, which the Zepbound label calls a GIP receptor and GLP-1 receptor agonist, acts on GIP too (Zepbound prescribing information).

A second target is a difference in how the two work, not by itself proof of a difference in results. What GIP may add is covered in what is tirzepatide, and the results come next.

What did the head-to-head trial find?

A trial published in 2025 compared the two directly. Adults with obesity but without type 2 diabetes were randomly assigned in equal numbers to the highest dose of tirzepatide (10 mg or 15 mg) or of semaglutide (1.7 mg or 2.4 mg) that they could tolerate, injected under the skin once a week for 72 weeks (New England Journal of Medicine, 2025).

At week 72, people on tirzepatide had lost an average of 20.2% of their body weight, and people on semaglutide 13.7% (New England Journal of Medicine, 2025).

Each medication was also tested against a placebo in a trial of its own (New England Journal of Medicine, 2021; New England Journal of Medicine, 2022). Those trials are in what is semaglutide and what is tirzepatide.

Is tirzepatide better than semaglutide?

The researchers' conclusion is narrower than "better." They found that among participants with obesity but without diabetes, tirzepatide was superior to semaglutide for reducing body weight and waist circumference at week 72 (New England Journal of Medicine, 2025).

Keep its limits in mind. It studied adults without type 2 diabetes, at the highest dose each person could tolerate, for 72 weeks, and its conclusion is about weight and waist size. It does not say which medication suits one person's health, other medications or budget. Those are for you and a licensed provider to weigh.

Tirzepatide vs Ozempic: which brand is approved for what?

Brand names make this comparison easy to mix up. Ozempic is a semaglutide brand approved for adults with type 2 diabetes: to improve blood sugar control along with diet and exercise, and to reduce certain heart and kidney risks (Ozempic prescribing information). Here is how the brands in this comparison line up:

So "tirzepatide vs Ozempic" can mean comparing a weight medication with a diabetes medication. Ask your provider which brand and which use you are comparing.

How do the side effects compare?

In the head-to-head trial, the most common side effects in both groups were digestive (gastrointestinal), and most were mild to moderate and occurred mainly while the dose was being stepped up (New England Journal of Medicine, 2025).

Each label also lists its own most common side effects. They come from separate labels, so read them side by side, not as a contest:

Each label's full list is in what is semaglutide and what is tirzepatide.

What do the two cost at Georgia med spas?

These are estimates from what Georgia med spas and skin clinics publish, not quotes, and we do not name any company. Both ranges are per month:

Before you set one range against the other, check that both prices are for the same kind of product, brand-name or compounded, and that each month includes the same things.

Questions to ask your provider

Ask for the medication, the brand and the monthly price in writing, so two offers compare like for like.

Sources

  1. Wegovy (semaglutide) injection and tablets, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
  2. Zepbound (tirzepatide) injection, FDA-approved prescribing information (Eli Lilly, label effective August 2026), DailyMed, National Library of Medicine
  3. Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine. 2025;393(1):26-36
  4. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002
  5. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216
  6. Ozempic (semaglutide) injection, FDA-approved prescribing information (Novo Nordisk, label effective June 2026), DailyMed, National Library of Medicine
  7. Mounjaro (tirzepatide) injection, FDA-approved prescribing information (Eli Lilly, label effective August 2026), DailyMed, National Library of Medicine

Prices mentioned here come from our Georgia med spa cost ranges, built from the prices and cost guides Georgia med spas publish on their public websites, collected September and October 2026.

Find a Georgia med spa